Our Belgian office – Cerba Research headquarters – was founded in 1983. In Belgium, we are embedded with the routine medical lab, CRI, which is part of the Cerba HealthCare Group. 

Cerba Research Montpellier, formerly known as HISTALIM, is our specialty histology lab. Focused on histopathology and immunohistochemistry, the lab allows clients to unleash biomarker information by measuring up to eight markers on one slide. 

Cerba Research IVD is our main in vitro diagnostics lab, providing complete and tailor-made solutions to help you evaluate your IVD device, develop quality control solutions, and market your IVD products. 

Cerba Research Rotterdam is a leading diagnostic and clinical trial operation service company supporting clinical and preclinical studies for drug and vaccine development to prevent and treat viral infections.

Rijswijk is a state-of-the-art laboratory specialized in (molecular) diagnostic testing and diagnostic assay development. The lab performs advanced (molecular) diagnostic testing on behalf of pharmaceutical companies and clinical laboratories, within the complex framework of preclinical studies and phase I-IV clinical trials.

Schaijk offers preclinical services including testing of efficacy, safety, PK and (immune) toxicology of drugs, antibodies, vaccines and antivirals targeting viral infectious diseases. The BSL-2 and BSL-3 facilities enable complicated experiments with highly pathogenic viruses. The qualified biotech staff and use of state of the art BSL2 and BSL3 in vivo facilities are key to a successful outcome of studies.

Cerba Research Canada (formerly CIRION BioPharma Research) is a Canadian based company, highly recognized for its integrated large molecules, biologics and biosimilars bioanalytical and global central laboratory services. CIRION is a large GLP certified facility (35,000 sq/f and 3,250 sq/m), CAP and CLIA accredited, with a global central laboratory footprint.

In 1996, Cerba Research put down its first roots outside Europe, in South Africa. We established a joint venture with Lancet Laboratories in 1999.

In 1996, Cerba Research put down its first roots outside Europe, in South Africa. We established a joint venture with Lancet Laboratories in 1999.

In 2012, Cerba Research established a partnership with DIAN Diagnostics, which has the largest network of laboratories across China. In 2018 we deepened our China footprint by partnering with Teddy Lab, a central lab in Shanghai. Teddy Lab is the result of a merger between DIAN and Tigermed.